If you're on Medicare and have struggled to afford weight-loss medications like Wegovy or Zepbound, help may finally be on the way. Starting July 1, 2026, a groundbreaking new federal program called the Medicare GLP-1 Bridge is making these life-changing medications available to millions of eligible seniors for just $50 a month — a fraction of their typical retail cost.

Here's everything you need to know about how this program works, who qualifies, and what it could mean for your health.

What Is the Medicare GLP-1 Bridge Program?

The Medicare GLP-1 Bridge is a short-term demonstration program run by the Centers for Medicare & Medicaid Services (CMS). It runs from July 1, 2026, through December 31, 2027, and is designed to fill a critical coverage gap for Medicare beneficiaries who need GLP-1 medications for weight loss.

Until now, Medicare has been legally prohibited from covering weight-loss medications under Part D — a restriction in place since Part D launched in 2006. The GLP-1 Bridge works around this limitation by operating outside of the standard Part D benefit, using a centralized payment system managed directly by CMS. This means your Part D plan doesn't need to take any special action — eligible beneficiaries can simply work with their doctor to access the program.

The program is also described as a "bridge" because it's meant to provide immediate access while CMS develops a longer-term solution — the Better Approaches to Lifestyle and Nutrition for Comprehensive hEalth (BALANCE) Model — potentially beginning in 2028.

Which GLP-1 Medications Are Covered Under Medicare in 2026?

Three FDA-approved weight-loss medications are available through the Medicare GLP-1 Bridge:

• Wegovy (semaglutide) — both injectable and tablet formulations
• Zepbound (tirzepatide) — KwikPen formulation only
• Foundayo — an oral GLP-1 option added to the program in April 2026

Note that diabetes-specific versions of these drugs — like Ozempic and Mounjaro — are not covered under the Bridge. Those medications continue to be covered by standard Part D plans when prescribed for diabetes or other approved conditions.

How Much Does the Medicare GLP-1 Bridge Cost?

Eligible beneficiaries pay a flat $50 copay per monthly supply, regardless of dosage. The federal government negotiated a net price of $245 per month with manufacturers Novo Nordisk and Eli Lilly — compared to retail prices that currently range from $149 to $699 per month without insurance.

One important caveat: the $50 copay does not count toward your Part D deductible, nor does it count toward the annual $2,100 out-of-pocket cap on prescription drug costs. Additionally, those who receive the Medicare Extra Help (low-income subsidy) program cannot apply that assistance to Bridge medications.

Who Is Eligible for the Medicare GLP-1 Bridge?

To participate in the Medicare GLP-1 Bridge program, you must meet several requirements.

Medicare Plan Enrollment Requirements

You must be actively enrolled in one of the following:

• A standalone Medicare Part D Prescription Drug Plan (PDP)
• A Medicare Advantage plan with drug coverage (MA-PD), including HMO and PPO plans
• Certain Special Needs Plans (SNPs)
  

Note that beneficiaries in PACE organizations, private fee-for-service plans, or employer group waiver plans are generally not eligible unless also enrolled in a standalone PDP.

BMI and Health Eligibility Criteria

Eligibility is tiered based on your body mass index (BMI) and existing health conditions. Importantly, your BMI is assessed at the time you first started GLP-1 therapy — not necessarily today. So if you began a GLP-1 medication in 2024 with a qualifying BMI but have since lost weight, you can still be eligible. Your prescriber simply needs to attest to your BMI at the time therapy began.

Here are the three eligibility tiers:

Tier 1 — BMI of 35 or higher: You automatically qualify, with no additional health condition required.

Tier 2 — BMI of 30 or higher: You qualify if you also have at least one of the following diagnosed conditions:

• Heart failure with preserved ejection fraction
• Uncontrolled hypertension (systolic blood pressure above 140 mmHg or diastolic above 90 mmHg while on two or more antihypertensive medications)
• Chronic kidney disease, Stage 3a or above

Tier 3 — BMI of 27 or higher: You qualify if you also have at least one of the following in your medical history:

• Pre-diabetes (as defined by American Diabetes Association guidelines)
• Prior heart attack
• Prior stroke
• Symptomatic peripheral artery disease

Who Is NOT Eligible for the Medicare GLP-1 Bridge?

If your GLP-1 medication is already coverable under standard Medicare Part D — for example, if you have Type 2 diabetes, moderate-to-severe obstructive sleep apnea, or established cardiovascular disease — you do not need the Bridge program. Your prescription will continue to be handled through your regular Part D plan.

How Do You Enroll in the Medicare GLP-1 Bridge?

You don't need to separately enroll in the Bridge program. To get access, your doctor submits a prior authorization request and a prescription directly to CMS's central processor (not your Part D plan). The prescriber must attest that you meet the clinical criteria. Once approved, your pharmacy will fill the prescription, and you'll pay the $50 copay at the counter.

Important Limitations to Know

While the Medicare GLP-1 Bridge is a major step forward, it's worth being aware of a few key limitations:

• The program is temporary. It ends December 31, 2027, and there's no guarantee of what happens next.
• Muscle loss is a risk for older adults. Rapid weight loss can sometimes contribute to loss of muscle mass. Seniors on GLP-1 therapy are encouraged to engage in regular physical activity and work with their healthcare provider to maintain muscle health and avoid nutritional deficiencies.
• The $50 copay may still be a barrier. For beneficiaries living on a small Social Security income, a $50 monthly cost may not be negligible. If cost is a concern, speak with your doctor about financial assistance options.

The Bottom Line: Is the Medicare GLP-1 Bridge Right for You?

The Medicare GLP-1 Bridge program represents a historic shift in how Medicare approaches weight loss and obesity treatment. For the first time, millions of seniors will have access to proven, effective weight-loss medications at an affordable price. If you or a loved one is on Medicare and struggling with obesity-related health conditions, this program is worth exploring.

Talk to your doctor today to find out if you meet the eligibility criteria and whether a GLP-1 medication might be right for you. For more information, visit the official CMS page at cms.gov/medicare/coverage/prescription-drug-coverage/medicare-glp-1-bridge.

This article is for informational purposes only and does not constitute medical or legal advice. Always consult your healthcare provider before starting any new medication.